Related Experiment Video
Updated: Mar 14, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Antiretroviral therapy in HIV-infected children
Conghai Fan1, Fengchao Zhang2, Chao Chen1
1Department of Anesthesiology, Xuzhou Children's Hospital, Xuzhou Medical University, Xuzhou, China.
Insights
Pediatric highly-active antiretroviral therapy (HAART) faces challenges like drug resistance and poor adherence, leading to treatment failure in children. This review examines these factors and current treatment strategies for better outcomes.
Area of Science:
- Pediatric infectious diseases
- Pharmacology
- HIV/AIDS research
Background:
- Pediatric highly-active antiretroviral therapy (HAART) has advanced significantly.
- However, a substantial proportion of children still experience treatment failure.
- Key issues include drug resistance, incorrect dosing, and poor patient adherence.
Purpose of the Study:
- To review the current status of antiretroviral therapy in children.
- To explore the interplay between HIV disease, antiretroviral drugs, and patient behavior.
- To discuss HIV viral characteristics and current combination antiretroviral drug classes.
Main Methods:
- Literature review focusing on pediatric HAART.
- Analysis of factors contributing to treatment failure.
- Examination of HIV viral properties and drug resistance mechanisms.
Main Results:
- Treatment failure in children is multifactorial, involving drug resistance, dosing issues, and adherence.
- Patient behavior significantly impacts HAART effectiveness.
- Understanding viral characteristics is crucial for effective drug combinations.
Conclusions:
- Addressing drug resistance, optimizing dosing, and improving adherence are critical for pediatric HAART success.
- Integrated approaches considering disease, drug, and patient factors are necessary.
- Continued research into viral characteristics and novel drug combinations is essential.
Abstract:
The pediatric highly-active antiretroviral therapy (HAART) has shown enormous progress in recent years but still, a high percentage of children continue to experience treatment failure. The main causes found responsible are the development of drug resistance, inadequate dosing and poor adherence. This review is aimed at exploring the current status of antiretroviral therapy in children with focus on the interaction between disease, drug and patient behavior, all of which are strongly correlated .An overview of HIV viral characteristics and of the available antiretroviral drug classes currently combined to avoid development of resistance has been also discussed.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Pharmacokinetics in Pediatric Patients: Drug Excretion
Sexually Transmitted Infections
Retroviruses
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pharmacokinetics in Pediatric Patients: Drug Metabolism

